Two Novel Variants in the FARSA Gene: A Case Study
Author Information
Author(s): Lomuscio Sonia, Cocciadiferro Dario, Petrizzelli Francesco, Liorni Niccolò, Mazza Tommaso, Allegorico Annalisa, Ullmann Nicola, Novelli Giuseppe, Cutrera Renato, Novelli Antonio
Primary Institution: Department of Biomedicine and Prevention, University of Rome Tor Vergata
Hypothesis
The study investigates the clinical and molecular spectrum of biallelic variants in the FARSA gene in a pediatric patient.
Conclusion
The findings expand the understanding of the FARSA-related phenotype and suggest potential treatment options for lung fibrosis in children.
Supporting Evidence
- The patient presented with interstitial lung disease and other severe symptoms.
- Two novel biallelic variants in the FARSA gene were identified.
- The patient was enrolled in a clinical trial for Nintedanib to treat lung fibrosis.
- Initial results from the treatment showed stability in respiratory function.
Takeaway
This study talks about a young girl with a rare genetic condition caused by changes in a specific gene, and how doctors are trying to help her breathe better.
Methodology
Next-generation sequencing (NGS) analysis was performed on the patient's DNA to identify genetic variants.
Limitations
The study is based on a single patient, which may limit the generalizability of the findings.
Participant Demographics
The participant was an 11-year-old girl, the only child of non-consanguineous, healthy parents.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website